1. Historical R&D of $1.6m + $0.6m cash in bank as at 31 Dec = $2.1m cash approx.
2. Expenditure this quarter given systems in place = not significant increase.
3. Revenue = Think it's safe to say it's increasing, not decreasing = Increase in cash at bank.
Recent partnerships:
1. Odournet - Thames Water recently awarded, other contracts to follow?
2. Sigma Space Corporation (NASA & Department of Defence) - No news (yet).
3. Libelium - Currently work in progress.
Recent contract wins:
1. As per ASX announcements.
Near term future = More announcements of contract wins, expecting record revenue.
Interested to know why posters think a CR will be required based on the above..
EVS Price at posting:
13.0¢ Sentiment: Buy Disclosure: Held
